Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP7

IMPROVE

Project reference: 602705
Funded under

Improving Prostate Cancer Outcome with Vectored Vaccines

From 2014-04-01 to 2018-03-31, ongoing project | IMPROVE Website

Project details

Total cost:

EUR 8 059 819,4

EU contribution:

EUR 6 000 000

Coordinated in:

United Kingdom

Call for proposal:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 2 800 000


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Administrative contact: Stephen Conway
Tel.: +44 1865 289800
Fax: +44 1865 289801
E-mail

Participants

OXFORD BIOMEDICA (UK) LIMITED
United Kingdom

EU contribution: EUR 2 125 000


OXFORD SCIENCE PARK MEDAWAR
OX4 4GA OXFORD
United Kingdom
Administrative contact: Tim Watts
Tel.: +44 1865783000
Fax: +44 1865783001
E-mail
GLAXOSMITHKLINE VACCINES SRL
Italy

EU contribution: EUR 300 000


VIA FIORENTINA 1
53100 SIENA
Italy
Administrative contact: Francesco Gulli
Tel.: +39 0577243089
E-mail
UNIVERSITE DE LAUSANNE
Switzerland

EU contribution: EUR 500 000


Quartier Unil-Centre Bâtiment Unicentre
1015 LAUSANNE
Switzerland
Administrative contact: Pedro Romero
Tel.: +41 21 3140198
E-mail
EXTERNAUTICS SPA
Italy

EU contribution: EUR 275 000


VIA FIORENTINA 1
53100 SIENA
Italy
Administrative contact: Paolo Sarmientos
Tel.: +39 0577231287
E-mail

Subjects

Life Sciences
Record Number: 109472 / Last updated on: 2015-10-23